Mark Lazenby on Universality of Psychosocial Concerns Following Cancer Diagnosis
Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the universality of psychosocial concerns following a cancer diagnosis.
Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the universality of psychosocial concerns following a cancer diagnosis.
Despite economic status or living conditions, Lazenby says, everyone around the world goes into an existential crisis after being diagnosed with cancer. Avery Weisman, MD, defined the first 100 days of a cancer diagnosis as the “period of existential plight.”
“I don’t care where the patient lives. That patient hears the ‘c-word’ and they go into a period of existential plight,” Lazenby says. “That’s the time in which we need to provide good psychosocial care, regardless of the patient’s living conditions.”
Adding Cediranib to Olaparib Increases Treatment Efficacy, But Raises Toxicity Concerns, in mCRPC
August 2nd 2025A regimen of cediranib and olaparib improved radiographic progression-free survival in patients with metastatic castration-resistant prostate cancer compared with olaparib monotherapy. However, the rate of dose reductions was doubled with the combination.
